Nonsteroidal Antiinflammatory Drugs, Cyclooxygenase-2, and the Kidneys

被引:18
|
作者
Rahman, Saadur [1 ]
Malcoun, Anthony [2 ,3 ]
机构
[1] Michigan State Univ, Garden City Hosp, Davenport, IA 52806 USA
[2] St John Macomb Hosp, St John Hlth Syst, Nephrol Fellowship Program, Warren, MI 48093 USA
[3] Hypertens Nephrol Associate, PC, Livonia, MI USA
来源
PRIMARY CARE | 2014年 / 41卷 / 04期
关键词
NSAIDS; COX-1; COX-2; Kidneys; Hypertension; Acute kidney injury; Electrolytes; Glomerular filtration rate; ACUTE INTERSTITIAL NEPHRITIS; ACUTE-RENAL-FAILURE; BLOOD-PRESSURE; NEPHROTIC SYNDROME; HYPERTENSIVE PATIENTS; INHIBITORS; RISK; PROSTAGLANDIN; THERAPY; DISEASE;
D O I
10.1016/j.pop.2014.09.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nonsteroidal antiinflammatory drugs (NSAIDs) are one of the most commonly used classes of medications in the world, which function by inhibiting the cyclooxygenase (COX) enzymes and downregulating the inflammatory pathway. COX enzymes are constitutively expressed in the kidneys and function to maintain a homeostatic environment in terms of maintaining the glomerular filtration rate, blood pressure, sodium, water, and osmotic regulation. When the COX enzymes are inhibited by NSAIDs, a multitude of renal and vascular complications occur. This article aims to enlighten primary care physicians of the complications that arise with NSAIDs from a renal perspective and to present some management strategies.
引用
收藏
页码:803 / +
页数:20
相关论文
共 50 条